dihydroberberine has been researched along with Anasarca in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ai, G; Chen, H; Chen, J; Li, C; Luo, C; Su, Z; Tan, L; Wang, Y; Xie, J; Zeng, H | 1 |
1 other study(ies) available for dihydroberberine and Anasarca
| Article | Year |
|---|---|
Dihydroberberine, a hydrogenated derivative of berberine firstly identified in Phellodendri Chinese Cortex, exerts anti-inflammatory effect via dual modulation of NF-κB and MAPK signaling pathways.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Berberine; Capillary Permeability; Carrageenan; Cytokines; Edema; Female; Foot; Male; MAP Kinase Signaling System; Mice; NF-kappa B; Phellodendron; Plant Bark; Xylenes | 2019 |